Peptide
Reference library
Educational peptide reference — research use only.
Research & educational use only
For laboratory and educational research only. Not for human or veterinary consumption. This is not medical advice. Always follow applicable laws and consult qualified professionals.
The calculator performs unit math for research reference. It must not be used to plan or guide dosing in humans or animals. Verify all figures independently in your lab protocol.
BPC-157 + TB-500 Mix
A pre-mixed recovery blend combining BPC-157 and TB-500 for tissue-research protocols.
- Half-life (approx.)
- Per-component — see individual entries (approx.)
- Diluent
- Bacteriostatic water (0.9% benzyl alcohol)
- Common vials
- 5, 10 mg
Half-life figures are literature approximations for educational reference — not pharmacokinetic advice.
Overview
This pre-mixed blend combines BPC-157 and TB-500 in a single vial for tissue-recovery research protocols. Formulation ratios vary — confirm individual component milligrams from analytical documentation before reconstitution calculations. Pre-mixed recovery blend combining angiogenic BPC-157 with migratory TB-500 pathways.
Structure & identity
Blend: BPC-157 + TB-500 (ratio formulation-dependent)
- Sequence / structure
- Blend: BPC-157 + TB-500 (ratio formulation-dependent)
Mechanism
Combines angiogenic/migration (TB-500) and growth-factor modulation (BPC-157) pathways. Dual soft-tissue repair mechanism is the rationale for combined tendon/ligament injury research.
Studies & clinical programs
Combined tendon/ligament injury models
Published research models
- Peer-reviewed literature documents endpoints under Combined tendon/ligament injury models experimental designs.
Research models in literature
- Combined tendon/ligament injury models
Literature highlights
- Dual recovery blend combines BPC-157 growth-factor modulation with TB-500 migration/angiogenesis pathways.
- Tendon and ligament injury models frequently cite combined soft-tissue repair endpoints.
- composition ratio verification essential — common 1:1 or fixed-mg formulations in preclinical literature.
Combination research notes
Verify mg ratio on analytical documentation — common 1:1 or fixed mg per vial.
Key targets & pathways
Research areas
Routes in research literature
Blend components
Also known as
Handling cautions
- Confirm per-peptide composition from analytical documentation before calculations
Stability & storage phases
| Phase | Condition | Guidance |
|---|---|---|
| Lyophilized blend | Refrigerated (2–8 °C), sealed | Confirm per-peptide mg breakdown on analytical documentation before storage; blended cakes may dissolve more slowly than single-peptide vials. |
| Reconstituted | Bacteriostatic water, refrigerated | Gently swirl until all components dissolve; stability limited by the most labile peptide in the mixture — label total and per-component concentration. |
| Working aliquots | Frozen (−20 °C) aliquots with component ratio noted | Calculate per-peptide exposure from verified blend ratios only; do not assume equal mg across components without analytical composition verification. |
Stability windows are formulation-dependent — verify published data and your lab SOP.
Reconstitution reference table
| Vial (mg) | Diluent (mL) | mcg/mL | Units @ 100 mcg | Units @ 250 mcg | Units @ 500 mcg |
|---|---|---|---|---|---|
| 5 | 2 | 2500.0 | 4 | 10 | 20 |
| 10 | 2 | 5000.0 | 2 | 5 | 10 |
U-100 insulin syringe scale (100 units = 1 mL). Illustrative only — not dosing guidance.
Reconstitution steps
- Confirm per-peptide composition from analytical documentation before any calculations
- Allow vial to reach room temperature (15–30 min)
- Swab stopper; inject diluent slowly down vial wall
- Gently swirl — blends may take longer to fully dissolve
- Label with date, total concentration, and component note
- Refrigerate; calculate per-peptide dose from verified ratios
Blend ratios vary by formulation; confirm per-component composition from analytical documentation before diluting.
Laboratory record checklist
- Compound identity recorded in lab notebook (name, lot, preparation date)
- Analytical identity cross-checked against published sequence or structure
- Potency or concentration documented from analytical certificate when available
- Purity or HPLC data filed when provided with research material
- Appearance noted: intact lyophilized cake or uniform powder
- Sterility / endotoxin report archived when available
- Storage temperature applied immediately per published stability guidance